Objectives: To determine the effectiveness of tympanoplasty with double fascia graft for treatment of tympanic perforation compared to simple fascia grafts. To determine if the composite graft has any advantage over the others used with respect to the hearing gain of patients and to determine the epithelialization time of the double fascia graft.

Materials and methods: A randomized, experimental, longitudinal, clinical study carried out from April 2019 to August 2020. Two groups were studied: group I with tympanoplasty with simple fascia and group II with double fascia graft. The patients were reviewed at 7, 30 and 60 days, assessing the integration of the graft and a control audiometry was performed at 60 days. The comparison between groups was made using ?2 or Fisher’s exact test for qualitative variables and Student’s t or U Mann-Whitney for quantitative one; p values less than 0.05 were considered significant.

Results: Forty patients were included in two groups, 20 in each one with a success rate at 60 days in 10 out of 20 in group of simple fascia graft and in 17 out of 20 in group of doble fascia graft with a statistically significant difference (p = 0.041). In hearing gain, no statistically significant differences were found (p = 0.741).

 

Conclusions: The double fascia graft have greater effectiveness in closing the tympanic perforation in patients with a history of chronic otitis media and previous surgeries compared to the conventional fascia graft, assessing its follow-up at 60 days. It represents a good alternative for handling complicated perforation, in addition to obtaining it does not require an extra cost. The epithelialization time coincided presenting an adequate integration at 60 days.